These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 13179727)

  • 21. No excuse for Rh failure.
    Robertson WO
    Northwest Med; 1969 Oct; 68(10):925 passim. PubMed ID: 4981721
    [No Abstract]   [Full Text] [Related]  

  • 22. [Serology and prophylaxis of Rhesus-caused hemolytic disease of the newborn].
    Maresch W
    Wien Med Wochenschr; 1966 Nov; 116(46):972-4. PubMed ID: 4966249
    [No Abstract]   [Full Text] [Related]  

  • 23. [Prevention of iso-immunization to blood factors].
    Santana Uribe A; Orduña Castrezana H; Aguirre De Maldonado M; Portillo Silva M
    Ginecol Obstet Mex; 1968 Dec; 24(146):683-7. PubMed ID: 4178492
    [No Abstract]   [Full Text] [Related]  

  • 24. [Obstetric problems raised by erythroblastosis].
    LOPEZ DORIGA
    Tokoginecol Pract; 1953; 12(113):303-8. PubMed ID: 13102542
    [No Abstract]   [Full Text] [Related]  

  • 25. Rh immunoglobulin prophylaxis.
    Riley EN
    NITA; 1983; 6(6):420-2. PubMed ID: 6316207
    [No Abstract]   [Full Text] [Related]  

  • 26. [Actual possibilities of prevention of serologic incompatibility].
    Breborowicz H; Gerwelowa H; Krawczyńska Z; Baraniecka K; Gruszczyńska J; Karowa L
    Pol Tyg Lek; 1968 Sep; 23(35):1305-7. PubMed ID: 4972438
    [No Abstract]   [Full Text] [Related]  

  • 27. [Practical problems in prevention of Rh-sensitization with immunological methods].
    Althoff W; Schellong G; Stahl M
    Minerva Med; 1969 Jul; 60(59):2905-15. PubMed ID: 4978556
    [No Abstract]   [Full Text] [Related]  

  • 28. [The status of Rh therapy 10 years after the initiation of the 1st studies].
    Schneider J
    Rev Chil Obstet Ginecol; 1973; 38(2):91-102. PubMed ID: 4215103
    [No Abstract]   [Full Text] [Related]  

  • 29. Maternal factors that influence the severity of erythroblastosis fetalis.
    TEATE HL
    Obstet Gynecol; 1955 Jun; 5(6):819-25. PubMed ID: 14384134
    [No Abstract]   [Full Text] [Related]  

  • 30. A review of the production and clinical use of intravenous Anti-D immunoglobulin.
    Walsh TJ; O'Riordan JP
    Ir Med J; 1982 Jul; 75(7):243-4. PubMed ID: 6813287
    [No Abstract]   [Full Text] [Related]  

  • 31. [Immunosuppressive mechanism and effect of immunoglobulins Anti D and Anti DK (IgG) in the prevention of hemolytic disease of the newborn caused by Rh incompatibility].
    Skrzypulec ZA
    Zentralbl Gynakol; 1973 Mar; 95(12):402-10. PubMed ID: 4634158
    [No Abstract]   [Full Text] [Related]  

  • 32. Prevention of primary Rh immunization: first report of the Western Canadian trial, 1966-1968.
    Can Med Assoc J; 1969 Jun; 100(22):1021-4. PubMed ID: 4977545
    [No Abstract]   [Full Text] [Related]  

  • 33. [Fetal hydrops in Rh iso-immunization with late pregnancy toxemia].
    ZACHARIAS K
    Zentralbl Gynakol; 1955; 77(17):653-6. PubMed ID: 14397726
    [No Abstract]   [Full Text] [Related]  

  • 34. [Systematic determination of iso-immunization to Rh antigens; French study based on 6,000 examinations].
    CHRISTIAENS L; GOUDEMAND M; SAMAILLE J
    Acta Chir Belg; 1954 Mar; 53(Suppl. 1):59-66. PubMed ID: 13188531
    [No Abstract]   [Full Text] [Related]  

  • 35. [Liver and placenta during hemolytic disease due to Rh iso-immunization (histologic study and deductions)].
    Bouissou H; Kanoun T; Bierme S; Bierme R
    Pathol Biol (Paris); 1969 Feb; 17(3):109-20. PubMed ID: 4978905
    [No Abstract]   [Full Text] [Related]  

  • 36. [On 6 cases of materno-fetal iso-immunization due to Rh factors without neonatal hemolytic disease].
    Di Marco A
    Clin Pediatr (Bologna); 1971 Jan; 53(1):27-37. PubMed ID: 5001051
    [No Abstract]   [Full Text] [Related]  

  • 37. [Premature therapeutic interruption of pregnancy in cases of anti-Rh iso-immunization].
    PIGEAUD H; GABRIEL H
    Gynecol Obstet (Paris); 1955; 54(2):202-8. PubMed ID: 14391767
    [No Abstract]   [Full Text] [Related]  

  • 38. Damage of the bone marrow due to Rh antibody.
    GIBLETT ER; VARELA JE; FINCH CA
    Pediatrics; 1956 Jan; 17(1):37-44. PubMed ID: 13280306
    [No Abstract]   [Full Text] [Related]  

  • 39. [On the prevention of Rh sensitization with anti D immunoglobulin].
    Jung K
    Dtsch Med Wochenschr; 1969 Aug; 94(33):1655-7. PubMed ID: 4978551
    [No Abstract]   [Full Text] [Related]  

  • 40. [Current methods of treatment and prevention of Rh-immunization and erythroblastosis].
    Ruponen S
    Suom Laakaril; 1966 Jul; 21(20):1695-8. PubMed ID: 4961256
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.